Captor Therapeutics is a publicly-listed (WSE:CTX) innovative drug discovery and development company focused on targeting the undruggable proteome using targeted protein degradation. Our mission is to transform lives of patients suffering from cancer, autoimmunity and neurodegenerative diseases. Our groundbreaking technology is perfectly suited to create new drug candidates with the potential to ease patients' burden and cure conditions that so far have only been poorly treatable.
Captor Therapeutics S.A. implements projects co-financed by the European Union. All information about the projects is available at: https://captortherapeutics.com/grant-projects.
Company Details
- Employees
- 84
- Founded
- -
- Address
- Duńska 11, Wrocław,dolnośląskie 54-427,poland
- Phone
- +48 537 869 089
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- captortherapeutics.com
- HQ
- Wrocław, dolnośląskie
Captor Therapeutics Sa Questions
Captor Therapeutics Sa's helpline number is +48 537 869 089
Captor Therapeutics Sa's website is captortherapeutics.com
Captor Therapeutics Sa's LinkedIn profile is https://ch.linkedin.com/company/captortherapeutics
Captor Therapeutics Sa has
84 employees.
View email and phone details for 84
employees at Captor Therapeutics Sa.
Captor Therapeutics Sa's industry is
Biotechnology Research
Captor Therapeutics Sa's top competitors are
Pure Biologics,
Jjp Biologics,
Selvita,
Celon Pharma S.a.,
Bioceltix,
Molecure,
Bioton S.a.,
Polpharma Biologics,
Ryvu Therapeutics,
Ardigen.
Captor Therapeutics Sa's support email address is info@captortherapeutics.com
Captor Therapeutics Sa's categories are Biotechnology Research
Captor Therapeutics Sa's founding year is 2017
